There is a great need for portable and rapid methods to improve screening of patients with brain injuries. Pre-hospital diagnosis can save lives, minimise disability and thereby save money for society.
Medfield Diagnostics AB (publ) aims to improve diagnosis of brain injuries. Early diagnosis will enable faster treatment, minimising unnecessary suffering, improving outcomes and lead to cost savings for healthcare and society.
Medfield develops microwave based systems intended for use in both in pre-hospital and hospital settings, primarily to screen patients with brain injuries.
Valberedningen för Medfield Diagnostics AB beslutade vid ett möte 2020-05-22 att föreslå kommande bolagstämma att föreslå advokat Olof Thorsell från Cedric Law som ordförande vid stämman, antalet ordinarie styrelseledamöter i… läs mer
Rapport om årsredovisningen Uttalanden Vi har utfört en revision av årsredovisningen för Medfield Diagnostics AB för räkenskapsåret 2019. Enligt vår uppfattning har årsredovisningen upprättats i enlighet med årsredovisningslagen och ger… läs mer
On September 10, Medfield Diagnostics AB hosted a Health Minister’s visit from Australia NSW. The Minister and his delegation were particularly interested in discussing Medfield’s opportunities to collaborate in the development of pre-hospital stroke and trauma care and the use of the Medfield MD100 system.
The background to the visit is Medfield’s ongoing collaboration with the Hunter Medical Research Institute, which includes clinical verification of Medfield’s MD100 system.
Great interest when Medfield participates in the ESOC and Vitalis conferences.
